Who Paid My Doc
Farhan Karim
Orthopaedic Surgery of the Spine Seattle, WA Doctor of Osteopathy
NPI 1154609337 CMS profile 1380781
908 Jefferson St, Seattle, WA 98104
General payments
$58,740
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$15,380
Through program year 2022, Farhan Karim of Seattle, WA is reported in the CMS Open Payments database as having received $58,740 across 300 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $15,380 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 71st percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $16,239 | 32 | |
| 2021 | General | $18,475 | 122 | |
| 2020 | General | $16,061 | 83 | |
| 2019 | General | $7,965 | 63 |
Beside peers
- Farhan Karim
- Orthopaedic Surgery of the Spine median
- Middle half of Orthopaedic Surgery of the Spine
- National median
In program year 2025, general payments to Farhan Karim were reported at $0. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.
Show as a table
| Year | Farhan Karim | Orthopaedic Surgery of the Spine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $7,965 | $2,106 | $337–$18,608 | $163 |
| 2020 | $16,061 | $1,213 | $156–$15,082 | $114 |
| 2021 | $18,475 | $1,834 | $271–$15,617 | $132 |
| 2022 | $16,239 | $2,015 | $320–$17,036 | $149 |
| 2023 | $0 | $1,925 | $336–$14,599 | $160 |
| 2024 | $0 | $2,110 | $341–$12,483 | $164 |
| 2025 | $0 | $2,061 | $347–$14,651 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
300 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Orthopaedic Surgery of the Spine in Washington
Antoine Tohmeh
Orthopaedic Surgery of the Spine · Spokane, WA
Rajiv Sethi
Orthopaedic Surgery of the Spine · Seattle, WA
Mark Freeborn
Orthopaedic Surgery of the Spine · Kirkland, WA
Alireza Anissipour
Orthopaedic Surgery of the Spine · Everett, WA
Richard Bransford
Orthopaedic Surgery of the Spine · Seattle, WA
Jens Chapman
Orthopaedic Surgery of the Spine · Seattle, WA
Related records
Orthopaedic Surgery of the Spine in Washington
Practitioners in the same specialty and state, ranked by reported value.
All Orthopaedic Surgery of the Spine
Everyone recorded under this specialty, nationwide.
Doctors in Washington
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.